PANVAC (National Cancer Institute) is another promising vaccinia or fowlpox-based vaccine expressing MUC1 and co-stimulatory molecules that is now in Phase II trials for several types of ...

Morse and coworkers investigated the safety and clinical and immunological efficacy of a DC vaccine modified with a recombinant Fowlpox vector encoding CEA and a triad of stimulatory molecules [rF-CEA ...

Objectives: Chordoma is a rare bone malignancy that affects the spine and skull base. Treatment dilemma leads to a high rate of local relapse and distant metastases. Molecular targeted therapy (MTT) ...